Indeed, in the realm of cancer therapy, targeting the FSP1-mediated anti-ferroptosis effect and promoting its pro-necroptosis or pro-apoptosis activity could enhance the sensitivity of tumor cells to radiotherapy and chemotherapy, thus providing a promising approach to overcoming drug and radiotherapy resistance. This evidence concerns the gene AIFM2 and cancer.